A Secure and Effective Project-Centric Research Platform
The increasing reliance of big pharma on a diverse range of external drug discovery collaborations has caused severe challenges in adapting existing data warehouse-centric Substance Activity Relationship (SAR) data platforms. This BIOVIA customer has built many large and complicated systems to support SAR data. However, these in-house systems were outdated and not easily adapted for the new types of data emerging from the shift toward biologics and novel bioactivity data. The exchange of data, Excel files and other documents using SharePoint or email was ineffective, inefficient and not secure.
The customer has leveraged BIOVIA ScienceCloud to overcome these challenges achieving up to 85% time savings preparing and manipulating data, while maintaining a single place to review results for all scientific collaborations.
Register today to learn more.